scholarly journals Pyrotinib in HER2 Heterogeneously Mutated or Amplified Advanced Non-small Cell Lung Cancer Patients: A Retrospective Real-world Study (PEARL)

2021 ◽  
Author(s):  
Guangjian Yang ◽  
Xuezhi Hao ◽  
Jiaqi Hu ◽  
Keke Dong ◽  
Haiyan Xu ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Real World ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients

Real-World Outcomes for Advanced Non-Small Cell Lung Cancer Patients Treated With a PD-L1 Inhibitor Beyond Progression

2020 ◽  
Vol 21 (5) ◽  
pp. 389-394.e3
Author(s):  
Thomas E. Stinchcombe ◽  
Rebecca A. Miksad ◽  
Anala Gossai ◽  
Sandra D. Griffith ◽  
Aracelis Z. Torres
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Real World ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients

Characteristics and Predictive Value of PD-L1 Status in Real-World Non–Small Cell Lung Cancer Patients

2018 ◽  
Vol 41 (6) ◽  
pp. 292-299 ◽  
Author(s):  
Jeng-Sen Tseng ◽  
Tsung-Ying Yang ◽  
Chih-Ying Wu ◽  
Wen-Hui Ku ◽  
Kun-Chieh Chen ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Real World ◽  
Predictive Value ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients

Real-world treatment patterns and survival of BRAF V600-mutated metastatic non-small cell lung cancer patients.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. 9096-9096
Author(s):  
Leora Horn ◽  
Joshua Bauml ◽  
Patrick M. Forde ◽  
Keith L. Davis ◽  
Nathaniel James Myall ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Real World ◽  
Treatment Patterns ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients
Sign in / Sign up

Export Citation Format

Share Document